XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.3
Share Based Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Schedule of Shares Issued and Fair Value of RSAs, RSUs

During the three and nine months ended September 30, 2023, the Company issued the following RSAs and RSUs pursuant to the Cambridge Bancorp 2017 Equity and Cash Incentive Plan (the “2017 Plan”). RSAs vest either over a three-year or five-year period. RSUs vest over a three-year period. The fair value of RSAs and RSUs are based upon the closing price of the Company’s common stock on the date of the applicable grant. The holders of RSAs participate fully in the rewards of stock ownership of the Company, including voting and dividend rights. The holders of RSUs do not participate in the rewards of stock ownership of the Company until they are vested.

 

 

 

Three Months Ended September 30, 2023

 

 

Nine Months Ended September 30, 2023

 

Type of Award

 

Shares Granted

 

 

Weighted Average Fair Value Per Share at Grant Date

 

 

Shares Granted

 

 

Weighted Average Fair Value Per Share at Grant Date

 

RSAs

 

 

882

 

 

$

56.75

 

 

 

16,348

 

 

$

81.47

 

RSUs

 

 

9,693

 

 

$

56.75

 

 

 

28,946

 

 

$

53.94

 

 

Schedule of Pre-tax Expense Associated with All Outstanding Non-vested RSAs, RSUs, Performance Based Restricted Stock Units and Related Tax Benefits

The following table presents the pre-tax expense associated with all outstanding non-vested RSAs, RSUs, and PRSUs, and the related tax benefits recognized:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

 

 

(dollars in thousands)

 

Share based compensation expense

 

$

589

 

 

$

697

 

 

$

1,759

 

 

$

2,288

 

Related tax benefits

 

$

164

 

 

$

195

 

 

$

491

 

 

$

639

 

 

Performance-Based Restricted Stock Units  
Schedule of Shares Issued and Fair Value of RSAs, RSUs

During the three and nine months ended September 30, 2023, the Company granted PRSUs from the 2017 Plan, as shown in the table below. PRSUs are subject to a three-year performance period and are earned based on performance factors, as determined, at the time of grant.

 

 

 

Three Months Ended September 30, 2023

 

 

Nine Months Ended September 30, 2023

 

Type of Award

 

Shares Granted

 

 

Weighted Average Fair Value Per Share at Grant Date

 

 

Shares Granted

 

 

Weighted Average Fair Value Per Share at Grant Date

 

PRSUs

 

 

 

 

$

 

 

 

31,744

 

 

$

59.19